Showing results (1061-1070 of 4,565) with videos related to
Sort By:
Pageof 457
Advances in Therapy|May 19, 2026
Impact of Obesity on Individuals in Saudi Arabia: A Real-World Patient and Physician SurveyFares Alruwaili, Fatimah Alkawai, Mohammed E Al-Sofiani, et al.Advances in Therapy|May 23, 2026
Psychometric Validation of the Weight and Emotions Scale (WES) in Adults with Obesity or OverweightChisom Kanu, Hayley Karn, Claudine Clucas, et al.Advances in Therapy|May 23, 2026
The Impact of Untreated Attention-Deficit/Hyperactivity Disorder on Motor Vehicle Accidents: A Systematic Review and Meta-AnalysisAnn Childress, Hirah Malik, Jim PotenzianoAdvances in Therapy|May 23, 2026
First-Line Pembrolizumab Plus Chemotherapy for Advanced Biliary Tract Cancer: China Subgroup Analysis of the Randomized Phase 3 KEYNOTE-966 StudyZhenggang Ren, Tingbo Liang, Shanzhi Gu, et al.Advances in Therapy|February 18, 2004
Master Amino acid Pattern as substitute for dietary proteins during a weight-loss diet to achieve the body's nitrogen balance equilibrium with essentially no caloriesM Lucà-Moretti, A Grandi, E Lucà, et al.Advances in Therapy|January 1, 2008
Caregiver preferences for pediatric asthma treatment delivery systemsWilliam Hitchcock, Michael Mellon, Marcos Memran, et al.Advances in Therapy|May 5, 2026
Effects of Guselkumab on Structural Damage Progression in Patients with Active Psoriatic ArthritisChristopher T Ritchlin, Laura C Coates, Philip J Mease, et al.Advances in Therapy|May 19, 2026
Randomized Controlled Trials Comparing the Standard of Care to Alternative Treatments in Patients with Resectable Locally Advanced Head and Neck Squamous Cell Carcinoma: A Systematic Literature ReviewAli Mojebi, Yuexin Tang, Sam Keeping, et al.Advances in Therapy|April 13, 2026
Evaluating Cost-Effectiveness in Relation to the Supporting Clinical Evidence Across the Type 2 Diabetes Continuum: A Review of Metformin and SGLT2isIan W Campbell, Kerstin M G Brand, Ulrike Gottwald-Hostalek, et al.Advances in Therapy|December 16, 2022
Identification of Secondary Prevention Patients Eligible for PCSK9 Inhibitors Therapy According to the Routine Clinical Practice in SpainJuan Cosin-Sales, Eduard Sidelnikov, Santiago Villamayor, et al.Pageof 457